Table 1 Clinical characteristics of the colon patients between the high- and low-risk groups
From: Identification of a ferroptosis-related gene signature predictive model in colon cancer
Variables | Group | ||
|---|---|---|---|
High risk | Low risk | P value | |
Age | 0.071 | ||
<65 | 61 (34.7%) | 79 (44.6%) | |
≥65 | 115 (65.3%) | 98 (55.4%) | |
Gender | 0.221 | ||
Female | 87 (49.4%) | 75 (42.4%) | |
Male | 89 (50.6%) | 102 (57.6%) | |
T stage | 0.002 | ||
T1-T2 | 22 (12.5%) | 45 (25.4%) | |
T3 | 127 (72.2%) | 118 (66.7%) | |
T4 | 27 (15.3%) | 14 (7.9%) | |
N stage | 0.006 | ||
N0 | 92 (52.3%) | 118 (66.7%) | |
N1 | 44 (25.0%) | 39 (22.0%) | |
N2 | 40 (22.7%) | 20 (11.3%) | |
M stage | 0.011 | ||
M0 | 140 (79.5%) | 159 (89.8%) | |
M1 | 36 (20.5%) | 18 (10.2%) | |
Chemotherapy | 0.549 | ||
No/unknown | 113 (64.2%) | 120 (67.8%) | |
Yes | 63 (35.8%) | 57 (32.2%) | |
Radiation | |||
No/unknown | 173 (98.3%) | 172 (97.2%) | 0.727 |
Yes | 3 (1.7%) | 5 (2.8%) | |